← Back to Search

N/A

Education Arm for Contraceptive Behavior

N/A
Waitlist Available
Led By Kayleigh Fischer, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male adolescents 15-21 years of age that are sexually active and have ever had vaginal sex that present to the St Louis Children's Hospital pediatric emergency department.
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial looks at whether an educational app about female hormonal contraception can help adolescent males in the pediatric emergency department.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Discussion rates
Secondary outcome measures
Fatherhood
Male value of partner discussion and hormonal contraceptive knowledge
Partner use of hormonal contraception

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Education ArmExperimental Treatment1 Intervention
This group will take a survey and be asked some sexual history questions including their contraceptive practices with their sexual partner(s). They will then watch the educational video on hormonal contraception and then be asked a few questions about the video. Then they will be asked for an email and phone number for follow up. They will then be followed up 3 months from their visit through their contact option of choice (email, text, or call) to take an additional survey with similar sexual history questions and current contraceptive practices including if they have discussed hormonal contraception with their female partners, if their female partners are now using hormonal contraception, and impregnation rates of female partners.
Group II: No Education ArmActive Control1 Intervention
This group will take a survey and be asked some sexual history questions including contraceptive practices with their sexual partner(s). They will then be asked for an email and phone number for follow up. They will then be followed up 3 months from their visit through their contact option of choice (email, text, or call) to take an additional survey with similar sexual history questions and current contraceptive practices including if they have discussed hormonal contraception with their female partners, if their female partners are now using hormonal contraception, and impregnation rates of female partners.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Education Arm
2018
N/A
~110

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,935 Previous Clinical Trials
2,299,700 Total Patients Enrolled
Kayleigh Fischer, MDPrincipal InvestigatorWashington Univeristy at St Louis
Fahd Ahmad, MDPrincipal InvestigatorWashington Univeristy at St Louis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must one fulfill to be eligible for enrollment in this trial?

"107 patients are needed to complete this clinical trial and must adhere to contraceptive practices while falling between the ages of 15 and 21."

Answered by AI

Does this research initiative admit individuals over forty years of age?

"According to the requirements, participants must be between 15 and 21 years old. Additionally, there are 8 trials available for those under 18 and 2 trials designated for seniors above 65."

Answered by AI

Are individuals currently being enrolled in this research initiative?

"According to clinicaltrials.gov, this research is not recruiting at the moment and hasn't been since September 7th 2022. Despite this, 12 other studies are actively seeking patients for their trials right now."

Answered by AI
~15 spots leftby Apr 2025